Skip to content
Adam Torkildson – Lifestyle
Author:
Vial
Vial Doses First Patient with Asthma in Phase 1b Study of Vial’s IL-13 x TSLP, a Bispecific Antibody Designed for Twice-Yearly Dosing
October 8, 2026